Observational Study
Copyright ©The Author(s) 2022.
World J Gastrointest Pharmacol Ther. Jul 5, 2022; 13(4): 57-66
Published online Jul 5, 2022. doi: 10.4292/wjgpt.v13.i4.57
Table 1 Demographic, clinical, nutritional, and bone density characteristics of patients with ulcerative colitis
Variable
UC (n = 68)
Control (n = 66)
P value
Age (yr), median (IR)39.0 (31.0-44.8)36.5 (29.0-43.0)0.484
Sex (female), n (%)42 (61.8)39 (59.1)0.867
Smoking (yes), n (%)2 (2.9)4 (6.1)0.437
Regular physical activity (yes), n (%)16 (23.5)15 (22.7)1.000
Duration of illness (yes), median (IR)5.0 (2.0-8.0)
Disease remission (yes), n (%)66 (97.1)
Intestinal resection history (yes), n (%)2 (2.9)
Extent of disease, n (%)
Proctitis13 (19.1)
Left colitis25 (36.8)
Extensive colitis30 (44.1)
Use of glucocorticoids (yes), n (%)12 (17.6)
Use ≥ 3 mo (yes), n (%)8 (66.7)
Accumulated dose of glucocorticoids (g), median (IR)1.7 (1.2-2.5)
Calcium supplement (yes), n (%)3 (4.4)0 (0)0.245
Vit D supplement (yes), n (%)5 (7.4)0 (0)0.058
Serum calcium (mmol/L), median (IR)2.3 (2.2-2.4)2.4 (2.3-2.4)0.065
Serum albumin (g/dL), median (IR)4.3 (4.1-4.5)4.4 (4.1-4.6)0.801
C-RP mg/dL, median (IR)1.4 (0.6-5.2)5.0 (1.0-6.2)0.004
BMI (kg/m2), median (IR)23.7 (20.6-26.5)26.3 (22.8-29.0)0.16
BMI classification, n (%)0.020
Thinness5 (7.4)1 (1.5)
Eutrophy40 (58.8)26 (39.4)
Overweight16 (23.5)28 (42.4)
Obesity7 (10.3)11 (16.7)
WC (cm), median (IR)80.5 (72.0-89.1)84.6 (79.7-93.7)0.156
LBM (kg), median (IR)40.1 (34.5-49.4)41.5 (35.3-52.2)0.604
BF (kg), median (IR)17.8 (11.5-22.6)23.2 (17.8-28.4)0.001
BF (%), median (IR)32.9 (23.7-37.6)34.8 (28.1-42.3)0.168
TBF (kg), median (IR)8.6 (6.3-12.5)12.8 (7.8-16.5)0.354
BMD (g/cm2), median (IR)
Femoral neck0.99 (0.90-1.07)1.06 (0.96-1.15)0.120
Lumbar spine1.16 (1.08-1.26)1.21 (1.13-1.31)0.120
Total body1.17 (1.11-1.24)1.22 (1.19-1.290.000